Feminizing Hormone Therapy Prescription Patterns and Cardiovascular Risk Factors in Aging Transgender Individuals in Australia

CONTEXT: The safety and efficacy of feminizing hormone therapy in aging transgender (trans) individuals is unclear. Current recommendations suggest transdermal estradiol beyond the age of 45 years, especially if cardiometabolic risk factors are present. OBJECTIVE: To evaluate feminizing hormone ther...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Endocrinol (Lausanne)
Egile Nagusiak: Balcerek, Matthew I., Nolan, Brendan J., Brownhill, Adam, Wong, Peggy, Locke, Peter, Zajac, Jeffrey D., Cheung, Ada S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2021
Gaiak:
Endocrinology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8313995/
https://ncbi.nlm.nih.gov/pubmed/34326812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.667403
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak